Christophe Bourdon, Orphazyme CEO
Orphazyme CEO departs for Leo Pharma as both companies face major restructurings
Someone else, it seems, will get the opportunity of trying to steer Orphazyme back to its former memeland glory.
In a bit of Danish biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
